Abstract
High glucose could change podocyte gene expression and subsequently induce podocyte damage through altered glucose metabolism. L‐carnitine is known to play a beneficial role in diabetes, however, there are no studies on the effect of L‐carnitine on podocyte alteration in high glucose condition. This study was to investigate whether L‐carnitine can attenuate diabetic podocyte injury through the prevention of slit diaphragm proteins loss. L‐carnitine treatment group showed an increased glucose uptake compared to control group, suggesting that utilization of glucose in the podocyte increased by L‐carnitine. L‐carnitine treatment also prevented the decreased mRNA expressions of nephrin and podocin in high glucose‐stimulated podocytes. However, the mRNA expression of CD2AP and ¥á‐actinin‐4 were not significantly changed by high glucose condition. Taken together, L‐carnitine could increase glucose uptake of podocyte in high glucose condition and its mechanism may be at least partly related to the upregulation of nephrin and podocin. Our results give information on the understanding the beneficial effects of L‐carnitine in diabetic nephropathy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
